Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Payer perceptions of the use of real-world evidence in oncology-based decision makingDiana Brixner, Joseph Biskupiak, Gary Oderda, et al.Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Evolving oncology care management trends in the United States: A survey among health care decision makersGary Oderda, Diana Brixner, Joseph Biskupiak, et al.BMC Health Services Research|January 13, 2021
Estimation of healthcare-related charges in women with BRCA mutations and breast cancerJoseph Biskupiak, Sudhir Unni, Claire Telford, et al.Journal of Managed Care Pharmacy : JMCP|August 30, 2011
All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspectiveCarrie McAdam-Marx, Lisa J McGarry, Christopher A Hane, et al.Journal of Cardiac Failure|June 10, 2022
Metolazone Versus Intravenous Chlorothiazide for Decompensated Heart Failure Sequential Nephron Blockade: A Retrospective Cohort StudyTamara Cisowska, Irene Z Pan, Joseph Biskupiak, et al.Pharmacotherapy|May 6, 2017
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart FailureJordan B King, Rashmee U Shah, Amy Sainski-Nguyen, et al.Journal of Clinical Lipidology|February 20, 2016
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United StatesSudhir K Unni, Ruben G W Quek, Joseph Biskupiak, et al.Journal of Managed Care & Specialty Pharmacy|November 22, 2021
Payer perceptions on the use of patient-reported outcomes in oncology decision makingGary Oderda, Diana Brixner, Joseph Biskupiak, et al.Journal of Medical Economics|January 5, 2021
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United StatesBeilei Cai, Zheng-Yi Zhou, Weiguang Xue, et al.Pharmacotherapy|February 4, 2016
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical CenterAdam P Bress, Jordan B King, Diana Brixner, et al.Pageof 6